Non-vitamin K antagonist oral anticoagulant, warfarin, and ABC pathway adherence on hierarchical outcomes: win ratio analysis of the COOL-AF registry
S Treewaree, GYH Lip… - Thrombosis and …, 2024 - thieme-connect.com
Background Atrial fibrillation (AF) Better Care (ABC) pathway adherence is associated with
improved outcomes. Clinical trials have shown that non-vitamin K antagonist oral …
improved outcomes. Clinical trials have shown that non-vitamin K antagonist oral …
[HTML][HTML] Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF
S Haas, AJ Camm, JP Bassand, P Angchaisuksiri… - American heart …, 2019 - Elsevier
Introduction A principal aim of the Global Anticoagulant Registry in the FIELD-Atrial
Fibrillation (GARFIELD-AF) was to document changes in treatment practice for patients with …
Fibrillation (GARFIELD-AF) was to document changes in treatment practice for patients with …
Adherence to anticoagulant guideline for atrial fibrillation improves outcomes in Asian population: the COOL-AF registry
R Krittayaphong, A Winijkul, R Kunjara-Na-Ayudhya… - Stroke, 2020 - Am Heart Assoc
Background and Purpose—Guideline adherent oral anticoagulant (OAC) management of
patients with nonvalvular atrial fibrillation has been associated with improved outcomes, but …
patients with nonvalvular atrial fibrillation has been associated with improved outcomes, but …
The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients
Aims To investigate the association between adherence to non-vitamin K antagonist oral
anticoagulant (NOAC) and clinical outcomes and to determine the optimal cut-off level of …
anticoagulant (NOAC) and clinical outcomes and to determine the optimal cut-off level of …
Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort …
T Forslund, B Wettermark, M Andersen… - EP …, 2018 - academic.oup.com
Abstract Aims Oral anticoagulants (OACs) effectively reduce the risk of stroke in atrial
fibrillation (AF). Three non-vitamin K antagonist OACs (NOACs) are introduced in regular …
fibrillation (AF). Three non-vitamin K antagonist OACs (NOACs) are introduced in regular …
Outcomes in a warfarin-treated population with atrial fibrillation
Importance Vitamin K antagonist (eg, warfarin) use is nowadays challenged by the non–
vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation …
vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation …
[HTML][HTML] Reducing stroke risk in atrial fibrillation: adherence to guidelines has improved, but patient persistence with anticoagulant therapy remains suboptimal
Atrial fibrillation (AF) is a significant risk factor for avoidable stroke. Among high-risk patients
with AF, stroke risk can be mitigated using oral anticoagulants (OACs), however reduction is …
with AF, stroke risk can be mitigated using oral anticoagulants (OACs), however reduction is …
Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naive patients with non-valvular …
Background The global real-life impact of non-vitamin K antagonist oral anticoagulants
(NOACs) introduction in the healthcare system in a setting of well-managed vitamin K …
(NOACs) introduction in the healthcare system in a setting of well-managed vitamin K …
Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS2 and CHA2DS2-VASc score levels and warfarin prescription for …
SA Chapman, CA St Hill, MM Little… - BMC health services …, 2017 - Springer
Background Ischemic stroke is a risk associated with atrial fibrillation (AF) and is estimated
to occur five times more often in afflicted patients than in those without AF. Anti-thrombotic …
to occur five times more often in afflicted patients than in those without AF. Anti-thrombotic …
Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
JM Farinha, ID Jones, GYH Lip - European Heart Journal …, 2022 - academic.oup.com
Atrial fibrillation (AF) is associated with an increased risk of stroke, which can be prevented
by the use of oral anticoagulation. Although non-vitamin K antagonist oral anticoagulants …
by the use of oral anticoagulation. Although non-vitamin K antagonist oral anticoagulants …